Susan Mary Galbraith
Corporate Officer/Principal at ASTRAZENECA PLC
Profile
Susan Mary Galbraith is currently the Executive VP-Oncology Research & Development at AstraZeneca PLC.
She previously worked as an Independent Non-Executive Director at Horizon Discovery Group Ltd.
from 2014 to 2020.
She also served as a Member-Supervisory Board at BB Biotech AG from 2020 to 2021.
Additionally, she held the position of Vice President-Oncology & Clinical Biomarkers at Bristol-Myers Squibb Pharmaceuticals Ltd.
from 2008 to 2010.
Dr. Galbraith's education includes an undergraduate degree from The University of Manchester, a graduate degree from the University of Cambridge, and a doctorate from the University of London.
Susan Mary Galbraith active positions
| Companies | Position | Start |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 2009-12-31 |
Former positions of Susan Mary Galbraith
| Companies | Position | End |
|---|---|---|
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Director/Board Member | 2023-12-31 |
| BB BIOTECH AG | Director/Board Member | 2021-07-01 |
| HORIZON DISCOVERY GROUP PLC | Director/Board Member | 2020-04-29 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 2009-12-31 |
Training of Susan Mary Galbraith
| University of London | Doctorate Degree |
| The University of Manchester | Undergraduate Degree |
| University of Cambridge | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| BB BIOTECH AG | Finance |
| Private companies | 3 |
|---|---|
Horizon Discovery Group Ltd.
 Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
- Stock Market
- Insiders
- Susan Mary Galbraith
